Literature DB >> 26862571

Annotated compound data for modulators of detergent-solubilised or lipid-reconstituted respiratory type II NADH dehydrogenase activity obtained by compound library screening.

Elyse A Dunn1, Gregory M Cook2, Adam Heikal2.   

Abstract

The energy-generating membrane protein NADH dehydrogenase (NDH-2), a proposed antibacterial drug target (see "Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs" Weinstein et al. 2005 [1]), was screened for modulators of activity in either detergent-solublised or lipid reconstituted (proteolipsome) form. Here we present an annotated list of compounds identified in a small-scale screen against NDH-2. The dataset contains information regarding the libraries screened, the identities of hit compounds and the physicochemical properties governing solubility and permeability. The implications of these data for future antibiotic discovery are discussed in our associated report, "Comparison of lipid and detergent enzyme environments for identifying inhibitors of membrane-bound energy-transducing proteins" [2].

Entities:  

Year:  2015        PMID: 26862571      PMCID: PMC4706612          DOI: 10.1016/j.dib.2015.12.019

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications table Value of the data The respiratory Type II NADH dehydrogenase (NDH-2) is an antimicrobial drug target and these annotated drug screening data provide information that may be used for further antimicrobial drug development. These data provide the identity of compounds from three libraries that either inhibit or stimulate NDH-2 activity in both detergent-solubilsed and lipid-reconstituted forms. The list of compounds is further annotated with ‘Rule of Five’ properties that may be used to inform future antimicrobial drug discovery and development.

Data

These data are the annotated hits identified by screening both detergent-solubilised (DS) and lipid-reconstituted (LR) respiratory Type II NADH dehydrogenase. The table contains the library; compound name, number of H-bond donors/acceptors, molecular weight, lipophilicity (logP) and degree of inhibition/stimulation for DS and LR protein (Table 1).
Table 1

Inhibitors/activators of detergent-solubilized (DS) or lipid-reconstituted (LR) NDH-2 activity, detected by screening compound libraries.

LibraryaCompound nameH-bond donorsbH-bond acceptorsbMolecular weightLogPb% control activity DSc% control activity LRc
LOPACI-OMe-Tyrphostin AG 53835437.19240±6.741.9±27.0
LOPACMyricetin68318.24042±14.229.9±22.4
LOPACMorin57302.24232±31.218.7±12.1
LOPACNordihydroguaiaretic acid (NDGA)44302.37433±24.418.7±23.1
LOPACReactive blue 2511840.111*44±7.336.53±44.5
LOPACTyrphostin AG 53845297.27137±7.438.1±28.2
LOPACTyrphostin AG 69833308.34163±2.167.6±2.3
LOPACTyrphostin AG 52823308.34354±21.255.3±15.9
LOPACIndirubin-3′-oxime32277.28250±12.147.6±25.6
LOPACHispidin35246.22048±3.253.7±19.4
LOPACTyrphostin AG 53766448.44122±18.457.0±16..9
LOPAC2,6-Difluoro-4-[2-(phenylsulfonylamino) ethylthio]phenoxyacetamide (PEPA)34402.442136±3.1133.7±15.2
LOPACCaffeic acid phenethyl ester24284.31443±9.0N/A
LOPACPiceatannol44244.25335±5.5N/A
LOPACTyrphostin AG 80833304.3127±16.5N/A
LOPAC4-Chloromercuribenzoic acid12257.162*48±0.3N/A
LOPACWIN 62,57711438.585142±1.8N/A
LOPACMJ3317514.498*149±22.7N/A
LOPACPentylenetetrazole00138.170132±2.9N/A
LOPACKenpaullone21327.18565±2.9N/A
LOPACPregnenolone sulphate sodium05418.531*68±1.1N/A
LOPACPhloretin42274.28165±3.8N/A
LOPACFarnesylthiosalicylic acid12358.55761±1.4N/A
LOPACTyrphostin AG 55533322.37353±1.2N/A
LOPACSuramin hexasodium6231429.193*61±10.0N/A
LOPACRottlerin58516.551*57±6.1N/A
NIH6H-Benzofuro[3,2-c] [1] benzopyran-6-one, 3,9-dihydroxy-NDND268.23ND65±22.2N/A
NIH6H-Pyrido[4,3-b]carbazole, 5,11-dimethyl-NDND246ND65±28.1N/A
NIHMichellamine B diacetic acid saltNDND877ND54±31.2N/A
NIH[9,9′-bi-4H-Naphtho[2,3-b]pyran]-4,4′-dione, 2,2′,3,3′-tetrahydro-5,5′,6,6′,8,8′-hexahydroxy-2,2′,3,3′-tetramethyl-NDND547ND33±11.5N/A
NIHMangostinNDND410ND19±15.3N/A
Quinonolone QuinoneCompound 18bNDND375.46ND41±22.746±19.8
Quinonolone QuinoneCompound 19NDND377.48ND36±16.138±5.1

Compound libraries were screened for inhibitors of NDH-2 NADH oxidation. Libraries screened included the Library of Pharmacologically Active Compounds (LOPAC), The NIH (National Institutes of Health) Natural Products Set II, and the Quinolinequinone Library.

ND=value not determined.

Data variation is expressed as standard deviation, N/A=not applicable.

Experimental design, materials and methods

Type II NADH dehydrogenase (NDH-2) was purified and reconstituted into proteoliposomes as described by Dunn et al. [2], [3]. Detergent-solubilised (DS) NDH-2 or lipid-reconstituted (LR) NDH-2 were screened by end point 96-well assay (340 nm, Varioskan® Flash Thermo Scientific, in the presence of 100 μM menadione and 20 μM test compound. The reaction was initiated using 200 μM NADH. Screening was carried out in technical triplicate against each compound library. NADH: menadione oxidoreductase inhibition/stimulation was calculated as a percentage of control activity for either DS or LR protein [2]. Compounds showing inhibition (≤70% control) or activation (≥130% control) in at least 2 of the 3 independent screening replicates were considered hits. Compound libraries screened were Library of Pharmacologically Active Compounds (LOPAC, SigmaAldrich), the Natural Products Set II (National Institutes of Health, USA) and the Quinolinequinone Library (Malaghan Institute of Medical Research, NZ) [4]. Hits were annotated with library of origin, chemical name and the drug-like properties governing in vivo absorption as described by the ‘Rule of Five’ namely, lipophilicity (logP), molecular weight, hydrogen bond donor and hydrogen bond acceptors [5]. Where necessary logP was predicted using ALOGPS software provided by the Virtual Computational Chemistry Laboratory [6].
Subject areaChemistry, Biology,
More specific subject areaAntibiotic discovery, drug discovery, microbiology
Type of dataTable
How data was acquiredSpectrophotometry using Varioskan® Flash (Thermo Scientific) 96-well plate reader.
Data formatAnalysed and annotated with physicochemical properties
Experimental factorsType II NADH dehydrogenase was purified and either remained in detergent solubilized form or reconstituted into proteoliposome form.
Experimental featuresSpectrophotometric determination of NADH oxidation at 340 nm
Data source locationUniversity of Otago, Dunedin, New Zealand
Data accessibilityData in article
  6 in total

Review 1.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

Authors:  C A Lipinski; F Lombardo; B W Dominy; P J Feeney
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

2.  Comparison of lipid and detergent enzyme environments for identifying inhibitors of membrane-bound energy-transducing proteins.

Authors:  Elyse A Dunn; Gregory M Cook; Adam Heikal
Journal:  J Microbiol Methods       Date:  2015-11-28       Impact factor: 2.363

3.  Virtual computational chemistry laboratory--design and description.

Authors:  Igor V Tetko; Johann Gasteiger; Roberto Todeschini; Andrea Mauri; David Livingstone; Peter Ertl; Vladimir A Palyulin; Eugene V Radchenko; Nikolay S Zefirov; Alexander S Makarenko; Vsevolod Yu Tanchuk; Volodymyr V Prokopenko
Journal:  J Comput Aided Mol Des       Date:  2005-06       Impact factor: 3.686

4.  The anti-cancer, anti-inflammatory and tuberculostatic activities of a series of 6,7-substituted-5,8-quinolinequinones.

Authors:  Benjamin J Mulchin; Christopher G Newton; James W Baty; Carole H Grasso; William John Martin; Michaela C Walton; Emma M Dangerfield; Catherine H Plunkett; Michael V Berridge; Jacquie L Harper; Mattie S M Timmer; Bridget L Stocker
Journal:  Bioorg Med Chem       Date:  2010-03-15       Impact factor: 3.641

5.  Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs.

Authors:  Edward A Weinstein; Takahiro Yano; Lin-Sheng Li; David Avarbock; Andrew Avarbock; Douglas Helm; Andrew A McColm; Ken Duncan; John T Lonsdale; Harvey Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

6.  Structure of the bacterial type II NADH dehydrogenase: a monotopic membrane protein with an essential role in energy generation.

Authors:  Adam Heikal; Yoshio Nakatani; Elyse Dunn; Marion R Weimar; Catherine L Day; Edward N Baker; J Shaun Lott; Leonid A Sazanov; Gregory M Cook
Journal:  Mol Microbiol       Date:  2014-01-21       Impact factor: 3.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.